Executives Shares 7 Life Sciences Predictions to Watch in 2023
HIT Consultant
JANUARY 13, 2023
The FDA and other governing bodies will increasingly hold pharma companies accountable for diversity in clinical trials. For progress to take place, companies will need to be held accountable for real, substantial changes to their clinical trial processes. Ariel Katz, CEO & Co-Founder at H1. Jane Myles, V.P.
Let's personalize your content